nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—HTR7—Parkinson's disease	0.141	0.192	CbGaD
Imipramine—SLC6A3—Parkinson's disease	0.123	0.168	CbGaD
Imipramine—HTR1A—Parkinson's disease	0.108	0.147	CbGaD
Imipramine—DRD2—Parkinson's disease	0.0918	0.125	CbGaD
Imipramine—CYP2E1—Parkinson's disease	0.0883	0.12	CbGaD
Imipramine—HTR2A—Parkinson's disease	0.0709	0.0965	CbGaD
Imipramine—CYP2D6—Parkinson's disease	0.0648	0.0883	CbGaD
Imipramine—ABCB1—Parkinson's disease	0.0463	0.063	CbGaD
Imipramine—HTR7—enteric nervous system—Parkinson's disease	0.00375	0.0362	CbGeAlD
Imipramine—HTR7—superior cervical ganglion—Parkinson's disease	0.00359	0.0346	CbGeAlD
Imipramine—HTR7—myenteric nerve plexus—Parkinson's disease	0.00284	0.0274	CbGeAlD
Imipramine—SLC6A2—locus ceruleus—Parkinson's disease	0.00257	0.0248	CbGeAlD
Imipramine—HTR7—locus ceruleus—Parkinson's disease	0.00248	0.0239	CbGeAlD
Imipramine—HTR2A—enteric nervous system—Parkinson's disease	0.00234	0.0226	CbGeAlD
Imipramine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00203	0.0196	CbGeAlD
Imipramine—HTR7—sympathetic nervous system—Parkinson's disease	0.00196	0.0189	CbGeAlD
Imipramine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00177	0.0171	CbGeAlD
Imipramine—KCND2—hindbrain—Parkinson's disease	0.00161	0.0155	CbGeAlD
Imipramine—HTR2A—locus ceruleus—Parkinson's disease	0.00154	0.0149	CbGeAlD
Imipramine—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00151	0.0146	CbGeAlD
Imipramine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00146	0.0141	CbGeAlD
Imipramine—HTR7—pons—Parkinson's disease	0.00143	0.0138	CbGeAlD
Imipramine—KCND3—hindbrain—Parkinson's disease	0.0014	0.0135	CbGeAlD
Imipramine—SLC6A2—autonomic nervous system—Parkinson's disease	0.00137	0.0132	CbGeAlD
Imipramine—HTR7—autonomic nervous system—Parkinson's disease	0.00132	0.0127	CbGeAlD
Imipramine—HTR2A—cerebellar cortex—Parkinson's disease	0.00126	0.0122	CbGeAlD
Imipramine—HTR1A—telencephalic ventricle—Parkinson's disease	0.00123	0.0119	CbGeAlD
Imipramine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00122	0.0118	CbGeAlD
Imipramine—HTR7—telencephalic ventricle—Parkinson's disease	0.00117	0.0113	CbGeAlD
Imipramine—DRD2—telencephalic ventricle—Parkinson's disease	0.00111	0.0107	CbGeAlD
Imipramine—SLC6A3—nerve—Parkinson's disease	0.000952	0.00919	CbGeAlD
Imipramine—HTR7—peripheral nervous system—Parkinson's disease	0.00095	0.00917	CbGeAlD
Imipramine—KCND2—brainstem—Parkinson's disease	0.00092	0.00888	CbGeAlD
Imipramine—HTR2A—pons—Parkinson's disease	0.00089	0.00859	CbGeAlD
Imipramine—KCND2—forebrain—Parkinson's disease	0.000888	0.00857	CbGeAlD
Imipramine—SLC22A3—tongue—Parkinson's disease	0.000876	0.00845	CbGeAlD
Imipramine—HTR2A—autonomic nervous system—Parkinson's disease	0.000821	0.00792	CbGeAlD
Imipramine—KCND3—brainstem—Parkinson's disease	0.000802	0.00774	CbGeAlD
Imipramine—KCND3—forebrain—Parkinson's disease	0.000774	0.00747	CbGeAlD
Imipramine—SLC6A2—nerve—Parkinson's disease	0.000768	0.00741	CbGeAlD
Imipramine—KCND2—cardiovascular system—Parkinson's disease	0.000751	0.00725	CbGeAlD
Imipramine—HTR7—nerve—Parkinson's disease	0.00074	0.00715	CbGeAlD
Imipramine—HTR2A—telencephalic ventricle—Parkinson's disease	0.000732	0.00707	CbGeAlD
Imipramine—SLC6A3—hindbrain—Parkinson's disease	0.000713	0.00688	CbGeAlD
Imipramine—DRD2—nerve—Parkinson's disease	0.0007	0.00676	CbGeAlD
Imipramine—HTR6—forebrain—Parkinson's disease	0.00066	0.00637	CbGeAlD
Imipramine—KCND3—cardiovascular system—Parkinson's disease	0.000655	0.00632	CbGeAlD
Imipramine—SLC6A4—hindbrain—Parkinson's disease	0.000653	0.00631	CbGeAlD
Imipramine—KCND2—medulla oblongata—Parkinson's disease	0.000641	0.00619	CbGeAlD
Imipramine—HTR2A—peripheral nervous system—Parkinson's disease	0.000592	0.00572	CbGeAlD
Imipramine—KCND2—midbrain—Parkinson's disease	0.000586	0.00566	CbGeAlD
Imipramine—HTR1A—hindbrain—Parkinson's disease	0.00058	0.0056	CbGeAlD
Imipramine—KCND2—spinal cord—Parkinson's disease	0.000572	0.00552	CbGeAlD
Imipramine—HTR7—hindbrain—Parkinson's disease	0.000554	0.00535	CbGeAlD
Imipramine—ADRA1A—hindbrain—Parkinson's disease	0.000535	0.00516	CbGeAlD
Imipramine—DRD2—hindbrain—Parkinson's disease	0.000524	0.00506	CbGeAlD
Imipramine—ADRA1D—forebrain—Parkinson's disease	0.000515	0.00497	CbGeAlD
Imipramine—KCND3—midbrain—Parkinson's disease	0.000511	0.00493	CbGeAlD
Imipramine—KCND2—head—Parkinson's disease	0.000508	0.00491	CbGeAlD
Imipramine—KCND2—nervous system—Parkinson's disease	0.000482	0.00465	CbGeAlD
Imipramine—KCND2—central nervous system—Parkinson's disease	0.000464	0.00448	CbGeAlD
Imipramine—HTR2A—nerve—Parkinson's disease	0.000462	0.00446	CbGeAlD
Imipramine—KCND2—cerebellum—Parkinson's disease	0.000454	0.00438	CbGeAlD
Imipramine—KCND3—head—Parkinson's disease	0.000443	0.00428	CbGeAlD
Imipramine—CHRM4—head—Parkinson's disease	0.000422	0.00407	CbGeAlD
Imipramine—KCND3—nervous system—Parkinson's disease	0.00042	0.00406	CbGeAlD
Imipramine—SLC22A3—embryo—Parkinson's disease	0.00042	0.00405	CbGeAlD
Imipramine—SLC6A3—brainstem—Parkinson's disease	0.000409	0.00394	CbGeAlD
Imipramine—KCND3—central nervous system—Parkinson's disease	0.000405	0.0039	CbGeAlD
Imipramine—CHRM4—nervous system—Parkinson's disease	0.0004	0.00386	CbGeAlD
Imipramine—CHRM2—forebrain—Parkinson's disease	0.000396	0.00382	CbGeAlD
Imipramine—KCND3—cerebellum—Parkinson's disease	0.000395	0.00382	CbGeAlD
Imipramine—HTR2C—brainstem—Parkinson's disease	0.000395	0.00381	CbGeAlD
Imipramine—SLC6A3—forebrain—Parkinson's disease	0.000394	0.00381	CbGeAlD
Imipramine—SLC22A1—forebrain—Parkinson's disease	0.000389	0.00375	CbGeAlD
Imipramine—CHRM4—central nervous system—Parkinson's disease	0.000385	0.00372	CbGeAlD
Imipramine—HTR2C—forebrain—Parkinson's disease	0.000381	0.00368	CbGeAlD
Imipramine—HTR6—head—Parkinson's disease	0.000378	0.00365	CbGeAlD
Imipramine—SLC6A4—brainstem—Parkinson's disease	0.000375	0.00361	CbGeAlD
Imipramine—KCND2—brain—Parkinson's disease	0.000368	0.00356	CbGeAlD
Imipramine—SLC6A4—forebrain—Parkinson's disease	0.000361	0.00349	CbGeAlD
Imipramine—CHRM1—forebrain—Parkinson's disease	0.00036	0.00348	CbGeAlD
Imipramine—HTR6—nervous system—Parkinson's disease	0.000358	0.00346	CbGeAlD
Imipramine—HTR2A—hindbrain—Parkinson's disease	0.000346	0.00334	CbGeAlD
Imipramine—HTR6—central nervous system—Parkinson's disease	0.000345	0.00333	CbGeAlD
Imipramine—CHRM2—cardiovascular system—Parkinson's disease	0.000335	0.00323	CbGeAlD
Imipramine—HTR1A—brainstem—Parkinson's disease	0.000333	0.00321	CbGeAlD
Imipramine—CHRM5—head—Parkinson's disease	0.00033	0.00318	CbGeAlD
Imipramine—SLC6A2—brainstem—Parkinson's disease	0.00033	0.00318	CbGeAlD
Imipramine—CHRM3—forebrain—Parkinson's disease	0.000322	0.00311	CbGeAlD
Imipramine—KCND3—brain—Parkinson's disease	0.000321	0.0031	CbGeAlD
Imipramine—HTR1A—forebrain—Parkinson's disease	0.000321	0.0031	CbGeAlD
Imipramine—SLC6A2—forebrain—Parkinson's disease	0.000318	0.00307	CbGeAlD
Imipramine—HTR7—brainstem—Parkinson's disease	0.000318	0.00307	CbGeAlD
Imipramine—CYP2D6—hindbrain—Parkinson's disease	0.000315	0.00304	CbGeAlD
Imipramine—CHRM5—nervous system—Parkinson's disease	0.000313	0.00302	CbGeAlD
Imipramine—HTR7—forebrain—Parkinson's disease	0.000307	0.00296	CbGeAlD
Imipramine—ADRA1A—brainstem—Parkinson's disease	0.000307	0.00296	CbGeAlD
Imipramine—CHRM4—brain—Parkinson's disease	0.000306	0.00295	CbGeAlD
Imipramine—CHRM1—cardiovascular system—Parkinson's disease	0.000304	0.00294	CbGeAlD
Imipramine—ADRA1B—head—Parkinson's disease	0.000302	0.00291	CbGeAlD
Imipramine—CHRM5—central nervous system—Parkinson's disease	0.000301	0.00291	CbGeAlD
Imipramine—DRD2—brainstem—Parkinson's disease	0.0003	0.0029	CbGeAlD
Imipramine—ADRA1A—forebrain—Parkinson's disease	0.000296	0.00286	CbGeAlD
Imipramine—ADRA1D—head—Parkinson's disease	0.000295	0.00285	CbGeAlD
Imipramine—DRD2—forebrain—Parkinson's disease	0.00029	0.0028	CbGeAlD
Imipramine—ADRA1B—nervous system—Parkinson's disease	0.000286	0.00276	CbGeAlD
Imipramine—KCNH2—forebrain—Parkinson's disease	0.000286	0.00276	CbGeAlD
Imipramine—ADRA1D—nervous system—Parkinson's disease	0.00028	0.0027	CbGeAlD
Imipramine—HTR2C—medulla oblongata—Parkinson's disease	0.000275	0.00266	CbGeAlD
Imipramine—ADRA1B—central nervous system—Parkinson's disease	0.000275	0.00266	CbGeAlD
Imipramine—HTR6—brain—Parkinson's disease	0.000274	0.00264	CbGeAlD
Imipramine—ORM1—spinal cord—Parkinson's disease	0.000273	0.00264	CbGeAlD
Imipramine—HTR1A—cardiovascular system—Parkinson's disease	0.000271	0.00262	CbGeAlD
Imipramine—ADRA1D—central nervous system—Parkinson's disease	0.000269	0.0026	CbGeAlD
Imipramine—SLC22A4—spinal cord—Parkinson's disease	0.000263	0.00254	CbGeAlD
Imipramine—SLC6A3—midbrain—Parkinson's disease	0.00026	0.00251	CbGeAlD
Imipramine—HTR7—cardiovascular system—Parkinson's disease	0.000259	0.0025	CbGeAlD
Imipramine—SLC6A3—spinal cord—Parkinson's disease	0.000254	0.00245	CbGeAlD
Imipramine—HTR2C—midbrain—Parkinson's disease	0.000252	0.00243	CbGeAlD
Imipramine—ADRA1A—cardiovascular system—Parkinson's disease	0.00025	0.00241	CbGeAlD
Imipramine—HTR2C—spinal cord—Parkinson's disease	0.000246	0.00237	CbGeAlD
Imipramine—KCNH2—cardiovascular system—Parkinson's disease	0.000242	0.00233	CbGeAlD
Imipramine—CHRM5—brain—Parkinson's disease	0.000239	0.00231	CbGeAlD
Imipramine—SLC6A4—midbrain—Parkinson's disease	0.000239	0.0023	CbGeAlD
Imipramine—SLC6A4—spinal cord—Parkinson's disease	0.000233	0.00225	CbGeAlD
Imipramine—ORM1—nervous system—Parkinson's disease	0.00023	0.00222	CbGeAlD
Imipramine—SLC6A2—medulla oblongata—Parkinson's disease	0.00023	0.00222	CbGeAlD
Imipramine—HRH1—forebrain—Parkinson's disease	0.000229	0.00221	CbGeAlD
Imipramine—Benazepril—MTHFR—Parkinson's disease	0.000228	0.0329	CrCbGaD
Imipramine—CHRM2—head—Parkinson's disease	0.000227	0.00219	CbGeAlD
Imipramine—SLC6A3—head—Parkinson's disease	0.000226	0.00218	CbGeAlD
Imipramine—SLC22A1—head—Parkinson's disease	0.000222	0.00215	CbGeAlD
Imipramine—ORM1—central nervous system—Parkinson's disease	0.000222	0.00214	CbGeAlD
Imipramine—HTR7—medulla oblongata—Parkinson's disease	0.000222	0.00214	CbGeAlD
Imipramine—ADRA1B—brain—Parkinson's disease	0.000219	0.00211	CbGeAlD
Imipramine—HTR2C—head—Parkinson's disease	0.000218	0.00211	CbGeAlD
Imipramine—HTR2A—embryo—Parkinson's disease	0.000216	0.00209	CbGeAlD
Imipramine—CHRM2—nervous system—Parkinson's disease	0.000215	0.00207	CbGeAlD
Imipramine—SLC6A3—nervous system—Parkinson's disease	0.000214	0.00207	CbGeAlD
Imipramine—ADRA1D—brain—Parkinson's disease	0.000214	0.00206	CbGeAlD
Imipramine—SLC22A3—head—Parkinson's disease	0.000213	0.00205	CbGeAlD
Imipramine—HTR1A—midbrain—Parkinson's disease	0.000212	0.00205	CbGeAlD
Imipramine—SLC22A1—nervous system—Parkinson's disease	0.000211	0.00204	CbGeAlD
Imipramine—SLC22A4—cerebellum—Parkinson's disease	0.000208	0.00201	CbGeAlD
Imipramine—HTR2C—nervous system—Parkinson's disease	0.000207	0.002	CbGeAlD
Imipramine—SLC6A4—head—Parkinson's disease	0.000207	0.002	CbGeAlD
Imipramine—HTR1A—spinal cord—Parkinson's disease	0.000207	0.002	CbGeAlD
Imipramine—CHRM2—central nervous system—Parkinson's disease	0.000207	0.002	CbGeAlD
Imipramine—KCNH2—medulla oblongata—Parkinson's disease	0.000206	0.00199	CbGeAlD
Imipramine—CHRM1—head—Parkinson's disease	0.000206	0.00199	CbGeAlD
Imipramine—SLC6A3—central nervous system—Parkinson's disease	0.000206	0.00199	CbGeAlD
Imipramine—SLC22A1—central nervous system—Parkinson's disease	0.000203	0.00196	CbGeAlD
Imipramine—HTR7—midbrain—Parkinson's disease	0.000203	0.00195	CbGeAlD
Imipramine—SLC22A3—nervous system—Parkinson's disease	0.000202	0.00195	CbGeAlD
Imipramine—SLC6A3—cerebellum—Parkinson's disease	0.000202	0.00194	CbGeAlD
Imipramine—HTR2C—central nervous system—Parkinson's disease	0.000199	0.00192	CbGeAlD
Imipramine—CYP2B6—cardiovascular system—Parkinson's disease	0.000198	0.00191	CbGeAlD
Imipramine—HTR2A—brainstem—Parkinson's disease	0.000198	0.00191	CbGeAlD
Imipramine—HTR7—spinal cord—Parkinson's disease	0.000198	0.00191	CbGeAlD
Imipramine—SLC6A4—nervous system—Parkinson's disease	0.000196	0.00189	CbGeAlD
Imipramine—CHRM1—nervous system—Parkinson's disease	0.000195	0.00189	CbGeAlD
Imipramine—SLC22A3—central nervous system—Parkinson's disease	0.000194	0.00187	CbGeAlD
Imipramine—DRD2—midbrain—Parkinson's disease	0.000191	0.00185	CbGeAlD
Imipramine—HTR2A—forebrain—Parkinson's disease	0.000191	0.00185	CbGeAlD
Imipramine—SLC6A4—central nervous system—Parkinson's disease	0.000189	0.00182	CbGeAlD
Imipramine—KCNH2—midbrain—Parkinson's disease	0.000189	0.00182	CbGeAlD
Imipramine—CHRM1—central nervous system—Parkinson's disease	0.000188	0.00182	CbGeAlD
Imipramine—CYP2E1—cardiovascular system—Parkinson's disease	0.000186	0.0018	CbGeAlD
Imipramine—CHRM3—head—Parkinson's disease	0.000185	0.00178	CbGeAlD
Imipramine—KCNH2—spinal cord—Parkinson's disease	0.000184	0.00178	CbGeAlD
Imipramine—HTR1A—head—Parkinson's disease	0.000184	0.00177	CbGeAlD
Imipramine—Epinastine—HTR7—Parkinson's disease	0.000183	0.0263	CrCbGaD
Imipramine—SLC6A2—head—Parkinson's disease	0.000182	0.00176	CbGeAlD
Imipramine—CYP2D6—brainstem—Parkinson's disease	0.000181	0.00174	CbGeAlD
Imipramine—HTR7—head—Parkinson's disease	0.000176	0.00169	CbGeAlD
Imipramine—CHRM3—nervous system—Parkinson's disease	0.000175	0.00169	CbGeAlD
Imipramine—CYP2D6—forebrain—Parkinson's disease	0.000174	0.00168	CbGeAlD
Imipramine—HTR1A—nervous system—Parkinson's disease	0.000174	0.00168	CbGeAlD
Imipramine—SLC6A2—nervous system—Parkinson's disease	0.000173	0.00167	CbGeAlD
Imipramine—ADRA1A—head—Parkinson's disease	0.000169	0.00163	CbGeAlD
Imipramine—SLC22A4—brain—Parkinson's disease	0.000169	0.00163	CbGeAlD
Imipramine—CHRM3—central nervous system—Parkinson's disease	0.000168	0.00163	CbGeAlD
Imipramine—HTR1A—central nervous system—Parkinson's disease	0.000168	0.00162	CbGeAlD
Imipramine—HTR7—nervous system—Parkinson's disease	0.000167	0.00161	CbGeAlD
Imipramine—SLC6A2—central nervous system—Parkinson's disease	0.000166	0.00161	CbGeAlD
Imipramine—DRD2—head—Parkinson's disease	0.000166	0.0016	CbGeAlD
Imipramine—CHRM2—brain—Parkinson's disease	0.000164	0.00158	CbGeAlD
Imipramine—HTR1A—cerebellum—Parkinson's disease	0.000164	0.00158	CbGeAlD
Imipramine—SLC6A3—brain—Parkinson's disease	0.000164	0.00158	CbGeAlD
Imipramine—KCNH2—head—Parkinson's disease	0.000164	0.00158	CbGeAlD
Imipramine—HTR2A—cardiovascular system—Parkinson's disease	0.000162	0.00156	CbGeAlD
Imipramine—SLC22A1—brain—Parkinson's disease	0.000161	0.00156	CbGeAlD
Imipramine—ADRA1A—nervous system—Parkinson's disease	0.000161	0.00155	CbGeAlD
Imipramine—HTR7—central nervous system—Parkinson's disease	0.00016	0.00155	CbGeAlD
Imipramine—CYP2E1—medulla oblongata—Parkinson's disease	0.000159	0.00153	CbGeAlD
Imipramine—HTR2C—brain—Parkinson's disease	0.000158	0.00153	CbGeAlD
Imipramine—DRD2—nervous system—Parkinson's disease	0.000157	0.00152	CbGeAlD
Imipramine—Maprotiline—HTR7—Parkinson's disease	0.000157	0.0227	CrCbGaD
Imipramine—HTR7—cerebellum—Parkinson's disease	0.000157	0.00151	CbGeAlD
Imipramine—KCNH2—nervous system—Parkinson's disease	0.000155	0.0015	CbGeAlD
Imipramine—ADRA1A—central nervous system—Parkinson's disease	0.000155	0.00149	CbGeAlD
Imipramine—SLC22A3—brain—Parkinson's disease	0.000154	0.00149	CbGeAlD
Imipramine—DRD2—central nervous system—Parkinson's disease	0.000152	0.00146	CbGeAlD
Imipramine—ADRA1A—cerebellum—Parkinson's disease	0.000151	0.00146	CbGeAlD
Imipramine—SLC6A4—brain—Parkinson's disease	0.00015	0.00145	CbGeAlD
Imipramine—CHRM1—brain—Parkinson's disease	0.000149	0.00144	CbGeAlD
Imipramine—KCNH2—central nervous system—Parkinson's disease	0.000149	0.00144	CbGeAlD
Imipramine—DRD2—cerebellum—Parkinson's disease	0.000148	0.00143	CbGeAlD
Imipramine—KCNH2—cerebellum—Parkinson's disease	0.000146	0.00141	CbGeAlD
Imipramine—CYP2E1—spinal cord—Parkinson's disease	0.000142	0.00137	CbGeAlD
Imipramine—ABCB1—embryo—Parkinson's disease	0.000142	0.00137	CbGeAlD
Imipramine—HTR2A—medulla oblongata—Parkinson's disease	0.000138	0.00133	CbGeAlD
Imipramine—Maprotiline—SLC6A3—Parkinson's disease	0.000138	0.0198	CrCbGaD
Imipramine—CYP2B6—head—Parkinson's disease	0.000134	0.0013	CbGeAlD
Imipramine—CHRM3—brain—Parkinson's disease	0.000134	0.00129	CbGeAlD
Imipramine—HTR1A—brain—Parkinson's disease	0.000133	0.00129	CbGeAlD
Imipramine—SLC6A2—brain—Parkinson's disease	0.000132	0.00127	CbGeAlD
Imipramine—HRH1—head—Parkinson's disease	0.000131	0.00127	CbGeAlD
Imipramine—CYP2B6—nervous system—Parkinson's disease	0.000127	0.00123	CbGeAlD
Imipramine—HTR7—brain—Parkinson's disease	0.000127	0.00123	CbGeAlD
Imipramine—Triflupromazine—DRD1—Parkinson's disease	0.000127	0.0183	CrCbGaD
Imipramine—HTR2A—midbrain—Parkinson's disease	0.000126	0.00122	CbGeAlD
Imipramine—CYP2E1—head—Parkinson's disease	0.000126	0.00122	CbGeAlD
Imipramine—ABCB1—forebrain—Parkinson's disease	0.000125	0.00121	CbGeAlD
Imipramine—HRH1—nervous system—Parkinson's disease	0.000124	0.0012	CbGeAlD
Imipramine—HTR2A—spinal cord—Parkinson's disease	0.000123	0.00119	CbGeAlD
Imipramine—ADRA1A—brain—Parkinson's disease	0.000123	0.00118	CbGeAlD
Imipramine—CYP2B6—central nervous system—Parkinson's disease	0.000123	0.00118	CbGeAlD
Imipramine—DRD2—brain—Parkinson's disease	0.00012	0.00116	CbGeAlD
Imipramine—HRH1—central nervous system—Parkinson's disease	0.00012	0.00116	CbGeAlD
Imipramine—CYP2E1—nervous system—Parkinson's disease	0.000119	0.00115	CbGeAlD
Imipramine—KCNH2—brain—Parkinson's disease	0.000119	0.00114	CbGeAlD
Imipramine—Clomipramine—GSTP1—Parkinson's disease	0.000118	0.017	CrCbGaD
Imipramine—Acepromazine—DRD1—Parkinson's disease	0.000117	0.0169	CrCbGaD
Imipramine—CYP2E1—central nervous system—Parkinson's disease	0.000115	0.00111	CbGeAlD
Imipramine—Thioproperazine—DRD1—Parkinson's disease	0.000115	0.0165	CrCbGaD
Imipramine—Pipotiazine—DRD1—Parkinson's disease	0.000113	0.0163	CrCbGaD
Imipramine—CYP2E1—cerebellum—Parkinson's disease	0.000112	0.00108	CbGeAlD
Imipramine—Prochlorperazine—DRD3—Parkinson's disease	0.00011	0.0158	CrCbGaD
Imipramine—HTR2A—head—Parkinson's disease	0.00011	0.00106	CbGeAlD
Imipramine—ABCB1—cardiovascular system—Parkinson's disease	0.000106	0.00102	CbGeAlD
Imipramine—Mianserin—HTR7—Parkinson's disease	0.000106	0.0152	CrCbGaD
Imipramine—HTR2A—nervous system—Parkinson's disease	0.000104	0.001	CbGeAlD
Imipramine—Maprotiline—DRD2—Parkinson's disease	0.000102	0.0147	CrCbGaD
Imipramine—Tripelennamine—CYP2D6—Parkinson's disease	0.000102	0.0147	CrCbGaD
Imipramine—HTR2A—central nervous system—Parkinson's disease	0.0001	0.000965	CbGeAlD
Imipramine—CYP2D6—head—Parkinson's disease	9.98e-05	0.000963	CbGeAlD
Imipramine—Cyamemazine—HTR2A—Parkinson's disease	9.96e-05	0.0143	CrCbGaD
Imipramine—Aprindine—CYP2D6—Parkinson's disease	9.96e-05	0.0143	CrCbGaD
Imipramine—Mianserin—DRD3—Parkinson's disease	9.95e-05	0.0143	CrCbGaD
Imipramine—HTR2A—cerebellum—Parkinson's disease	9.77e-05	0.000943	CbGeAlD
Imipramine—Acepromazine—HTR1A—Parkinson's disease	9.76e-05	0.014	CrCbGaD
Imipramine—CYP2B6—brain—Parkinson's disease	9.73e-05	0.000939	CbGeAlD
Imipramine—CYP3A4—nervous system—Parkinson's disease	9.61e-05	0.000928	CbGeAlD
Imipramine—Thioproperazine—HTR1A—Parkinson's disease	9.54e-05	0.0137	CrCbGaD
Imipramine—HRH1—brain—Parkinson's disease	9.5e-05	0.000917	CbGeAlD
Imipramine—CYP2D6—nervous system—Parkinson's disease	9.46e-05	0.000913	CbGeAlD
Imipramine—Pipotiazine—HTR1A—Parkinson's disease	9.38e-05	0.0135	CrCbGaD
Imipramine—Cyclobenzaprine—HTR2A—Parkinson's disease	9.26e-05	0.0133	CrCbGaD
Imipramine—Mianserin—SLC6A3—Parkinson's disease	9.26e-05	0.0133	CrCbGaD
Imipramine—CYP3A4—central nervous system—Parkinson's disease	9.25e-05	0.000893	CbGeAlD
Imipramine—Epinastine—HTR2A—Parkinson's disease	9.19e-05	0.0132	CrCbGaD
Imipramine—CYP2E1—brain—Parkinson's disease	9.13e-05	0.000881	CbGeAlD
Imipramine—CYP2D6—central nervous system—Parkinson's disease	9.11e-05	0.000879	CbGeAlD
Imipramine—ABCB1—medulla oblongata—Parkinson's disease	9.06e-05	0.000874	CbGeAlD
Imipramine—Triflupromazine—DRD2—Parkinson's disease	8.95e-05	0.0129	CrCbGaD
Imipramine—CYP2D6—cerebellum—Parkinson's disease	8.9e-05	0.000859	CbGeAlD
Imipramine—Cyclobenzaprine—CYP2D6—Parkinson's disease	8.47e-05	0.0122	CrCbGaD
Imipramine—Epinastine—CYP2D6—Parkinson's disease	8.41e-05	0.0121	CrCbGaD
Imipramine—Acepromazine—DRD2—Parkinson's disease	8.28e-05	0.0119	CrCbGaD
Imipramine—ABCB1—midbrain—Parkinson's disease	8.28e-05	0.000799	CbGeAlD
Imipramine—Methotrimeprazine—DRD3—Parkinson's disease	8.18e-05	0.0118	CrCbGaD
Imipramine—Mianserin—HTR1A—Parkinson's disease	8.11e-05	0.0117	CrCbGaD
Imipramine—Thioproperazine—DRD2—Parkinson's disease	8.1e-05	0.0117	CrCbGaD
Imipramine—ABCB1—spinal cord—Parkinson's disease	8.08e-05	0.000779	CbGeAlD
Imipramine—Methotrimeprazine—DRD1—Parkinson's disease	8.03e-05	0.0116	CrCbGaD
Imipramine—Pipotiazine—DRD2—Parkinson's disease	7.96e-05	0.0115	CrCbGaD
Imipramine—HTR2A—brain—Parkinson's disease	7.94e-05	0.000766	CbGeAlD
Imipramine—Maprotiline—HTR2A—Parkinson's disease	7.91e-05	0.0114	CrCbGaD
Imipramine—Mequitazine—CYP2D6—Parkinson's disease	7.91e-05	0.0114	CrCbGaD
Imipramine—Trimipramine—SLC6A3—Parkinson's disease	7.79e-05	0.0112	CrCbGaD
Imipramine—Prochlorperazine—DRD2—Parkinson's disease	7.61e-05	0.011	CrCbGaD
Imipramine—Nortriptyline—HTR1A—Parkinson's disease	7.25e-05	0.0104	CrCbGaD
Imipramine—Maprotiline—CYP2D6—Parkinson's disease	7.24e-05	0.0104	CrCbGaD
Imipramine—CYP2D6—brain—Parkinson's disease	7.23e-05	0.000698	CbGeAlD
Imipramine—ABCB1—head—Parkinson's disease	7.18e-05	0.000693	CbGeAlD
Imipramine—Promazine—DRD1—Parkinson's disease	6.96e-05	0.01	CrCbGaD
Imipramine—Mianserin—DRD2—Parkinson's disease	6.88e-05	0.00991	CrCbGaD
Imipramine—Trimipramine—HTR1A—Parkinson's disease	6.82e-05	0.00982	CrCbGaD
Imipramine—Desipramine—SLC6A3—Parkinson's disease	6.81e-05	0.0098	CrCbGaD
Imipramine—ABCB1—nervous system—Parkinson's disease	6.8e-05	0.000657	CbGeAlD
Imipramine—Chlorpromazine—HTR7—Parkinson's disease	6.64e-05	0.00955	CrCbGaD
Imipramine—Amitriptyline—HTR7—Parkinson's disease	6.56e-05	0.00944	CrCbGaD
Imipramine—ABCB1—central nervous system—Parkinson's disease	6.55e-05	0.000632	CbGeAlD
Imipramine—Doxepin—HTR1A—Parkinson's disease	6.5e-05	0.00936	CrCbGaD
Imipramine—ABCB1—cerebellum—Parkinson's disease	6.4e-05	0.000618	CbGeAlD
Imipramine—Acepromazine—HTR2A—Parkinson's disease	6.4e-05	0.00921	CrCbGaD
Imipramine—Thioproperazine—HTR2A—Parkinson's disease	6.26e-05	0.009	CrCbGaD
Imipramine—Chlorpromazine—DRD3—Parkinson's disease	6.24e-05	0.00898	CrCbGaD
Imipramine—Amitriptyline—DRD3—Parkinson's disease	6.17e-05	0.00888	CrCbGaD
Imipramine—Pipotiazine—HTR2A—Parkinson's disease	6.15e-05	0.00886	CrCbGaD
Imipramine—Nortriptyline—DRD2—Parkinson's disease	6.15e-05	0.00886	CrCbGaD
Imipramine—Chlorpromazine—DRD1—Parkinson's disease	6.12e-05	0.00882	CrCbGaD
Imipramine—Epinastine—ABCB1—Parkinson's disease	6e-05	0.00864	CrCbGaD
Imipramine—Desipramine—HTR1A—Parkinson's disease	5.97e-05	0.00859	CrCbGaD
Imipramine—Nortriptyline—CYP2E1—Parkinson's disease	5.92e-05	0.00852	CrCbGaD
Imipramine—Trimipramine—DRD2—Parkinson's disease	5.79e-05	0.00834	CrCbGaD
Imipramine—Methotrimeprazine—DRD2—Parkinson's disease	5.66e-05	0.00815	CrCbGaD
Imipramine—Pipotiazine—CYP2D6—Parkinson's disease	5.63e-05	0.0081	CrCbGaD
Imipramine—Promethazine—DRD2—Parkinson's disease	5.58e-05	0.00803	CrCbGaD
Imipramine—Doxepin—DRD2—Parkinson's disease	5.52e-05	0.00795	CrCbGaD
Imipramine—Methotrimeprazine—CYP2E1—Parkinson's disease	5.45e-05	0.00784	CrCbGaD
Imipramine—Prochlorperazine—CYP2D6—Parkinson's disease	5.38e-05	0.00774	CrCbGaD
Imipramine—Mianserin—HTR2A—Parkinson's disease	5.32e-05	0.00766	CrCbGaD
Imipramine—ABCB1—brain—Parkinson's disease	5.2e-05	0.000502	CbGeAlD
Imipramine—Orphenadrine—CYP2E1—Parkinson's disease	5.18e-05	0.00745	CrCbGaD
Imipramine—Maprotiline—ABCB1—Parkinson's disease	5.17e-05	0.00744	CrCbGaD
Imipramine—Chlorpromazine—HTR1A—Parkinson's disease	5.09e-05	0.00732	CrCbGaD
Imipramine—Desipramine—DRD2—Parkinson's disease	5.07e-05	0.00729	CrCbGaD
Imipramine—Amitriptyline—HTR1A—Parkinson's disease	5.03e-05	0.00724	CrCbGaD
Imipramine—Promazine—DRD2—Parkinson's disease	4.91e-05	0.00706	CrCbGaD
Imipramine—Desipramine—CYP2E1—Parkinson's disease	4.88e-05	0.00702	CrCbGaD
Imipramine—Clomipramine—HTR2A—Parkinson's disease	4.86e-05	0.007	CrCbGaD
Imipramine—Mianserin—CYP2D6—Parkinson's disease	4.86e-05	0.007	CrCbGaD
Imipramine—Nortriptyline—HTR2A—Parkinson's disease	4.75e-05	0.00684	CrCbGaD
Imipramine—Triflupromazine—ABCB1—Parkinson's disease	4.52e-05	0.0065	CrCbGaD
Imipramine—Trimipramine—HTR2A—Parkinson's disease	4.48e-05	0.00644	CrCbGaD
Imipramine—Clomipramine—CYP2D6—Parkinson's disease	4.45e-05	0.0064	CrCbGaD
Imipramine—Methotrimeprazine—HTR2A—Parkinson's disease	4.38e-05	0.0063	CrCbGaD
Imipramine—Nortriptyline—CYP2D6—Parkinson's disease	4.35e-05	0.00626	CrCbGaD
Imipramine—Chlorpromazine—DRD2—Parkinson's disease	4.32e-05	0.00622	CrCbGaD
Imipramine—Promethazine—HTR2A—Parkinson's disease	4.31e-05	0.0062	CrCbGaD
Imipramine—Amitriptyline—DRD2—Parkinson's disease	4.27e-05	0.00614	CrCbGaD
Imipramine—Doxepin—HTR2A—Parkinson's disease	4.27e-05	0.00614	CrCbGaD
Imipramine—Chlorpromazine—CYP2E1—Parkinson's disease	4.16e-05	0.00598	CrCbGaD
Imipramine—Amitriptyline—CYP2E1—Parkinson's disease	4.11e-05	0.00591	CrCbGaD
Imipramine—Trimipramine—CYP2D6—Parkinson's disease	4.09e-05	0.00589	CrCbGaD
Imipramine—Diphenhydramine—CYP2D6—Parkinson's disease	4.02e-05	0.00579	CrCbGaD
Imipramine—Methotrimeprazine—CYP2D6—Parkinson's disease	4e-05	0.00576	CrCbGaD
Imipramine—Promethazine—CYP2D6—Parkinson's disease	3.94e-05	0.00567	CrCbGaD
Imipramine—Desipramine—HTR2A—Parkinson's disease	3.91e-05	0.00563	CrCbGaD
Imipramine—Doxepin—CYP2D6—Parkinson's disease	3.9e-05	0.00561	CrCbGaD
Imipramine—Promazine—HTR2A—Parkinson's disease	3.79e-05	0.00546	CrCbGaD
Imipramine—Carbamazepine—ABCB1—Parkinson's disease	3.77e-05	0.00543	CrCbGaD
Imipramine—Desipramine—CYP2D6—Parkinson's disease	3.58e-05	0.00515	CrCbGaD
Imipramine—Chlorpromazine—HTR2A—Parkinson's disease	3.34e-05	0.0048	CrCbGaD
Imipramine—Amitriptyline—HTR2A—Parkinson's disease	3.3e-05	0.00475	CrCbGaD
Imipramine—Clomipramine—ABCB1—Parkinson's disease	3.18e-05	0.00457	CrCbGaD
Imipramine—Chlorpromazine—CYP2D6—Parkinson's disease	3.05e-05	0.00439	CrCbGaD
Imipramine—Amitriptyline—CYP2D6—Parkinson's disease	3.02e-05	0.00434	CrCbGaD
Imipramine—Trimipramine—ABCB1—Parkinson's disease	2.92e-05	0.00421	CrCbGaD
Imipramine—Promethazine—ABCB1—Parkinson's disease	2.81e-05	0.00405	CrCbGaD
Imipramine—Doxepin—ABCB1—Parkinson's disease	2.79e-05	0.00401	CrCbGaD
Imipramine—Desipramine—ABCB1—Parkinson's disease	2.56e-05	0.00368	CrCbGaD
Imipramine—Chlorpromazine—ABCB1—Parkinson's disease	2.18e-05	0.00314	CrCbGaD
Imipramine—Amitriptyline—ABCB1—Parkinson's disease	2.15e-05	0.0031	CrCbGaD
Imipramine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	4.55e-06	2.94e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	4.55e-06	2.94e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	4.54e-06	2.93e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	4.52e-06	2.92e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	4.5e-06	2.91e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MAOB—Parkinson's disease	4.5e-06	2.91e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	4.5e-06	2.91e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—APOE—Parkinson's disease	4.49e-06	2.9e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—GPX1—Parkinson's disease	4.38e-06	2.83e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—APOE—Parkinson's disease	4.38e-06	2.83e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—MTHFR—Parkinson's disease	4.38e-06	2.83e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—APOE—Parkinson's disease	4.37e-06	2.83e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	4.36e-06	2.82e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—COMT—Parkinson's disease	4.3e-06	2.78e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	4.3e-06	2.78e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	4.29e-06	2.77e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GSTP1—Parkinson's disease	4.28e-06	2.77e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.28e-06	2.77e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—MAOA—Parkinson's disease	4.27e-06	2.76e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—INS—Parkinson's disease	4.24e-06	2.74e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—INS—Parkinson's disease	4.24e-06	2.74e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—HMOX1—Parkinson's disease	4.22e-06	2.73e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	4.22e-06	2.73e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—COMT—Parkinson's disease	4.22e-06	2.72e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CTGF—Parkinson's disease	4.21e-06	2.72e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GSTP1—Parkinson's disease	4.2e-06	2.71e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	4.19e-06	2.71e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—MAOA—Parkinson's disease	4.19e-06	2.71e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	4.15e-06	2.68e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NGF—Parkinson's disease	4.15e-06	2.68e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—HMOX1—Parkinson's disease	4.14e-06	2.67e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	4.13e-06	2.67e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—DDC—Parkinson's disease	4.13e-06	2.67e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CTGF—Parkinson's disease	4.11e-06	2.66e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	4.09e-06	2.64e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	4.08e-06	2.64e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—APOE—Parkinson's disease	4.08e-06	2.63e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	4.06e-06	2.63e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ABCB1—Parkinson's disease	4.05e-06	2.62e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	4.05e-06	2.62e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—MTHFR—Parkinson's disease	4.04e-06	2.61e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	4.02e-06	2.6e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	4.01e-06	2.59e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	4e-06	2.59e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—INS—Parkinson's disease	4e-06	2.59e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ABCB1—Parkinson's disease	3.97e-06	2.57e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	3.97e-06	2.56e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	3.95e-06	2.56e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	3.95e-06	2.56e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	3.95e-06	2.55e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	3.94e-06	2.55e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GSTM1—Parkinson's disease	3.94e-06	2.54e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	3.93e-06	2.54e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	3.93e-06	2.54e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	3.93e-06	2.54e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	3.92e-06	2.53e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	3.9e-06	2.52e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.9e-06	2.52e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	3.9e-06	2.52e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	3.88e-06	2.51e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—NQO1—Parkinson's disease	3.88e-06	2.51e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	3.88e-06	2.51e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CTGF—Parkinson's disease	3.87e-06	2.5e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	3.87e-06	2.5e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	3.87e-06	2.5e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GSTM1—Parkinson's disease	3.86e-06	2.49e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	3.83e-06	2.48e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—INS—Parkinson's disease	3.83e-06	2.48e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.83e-06	2.48e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—TH—Parkinson's disease	3.83e-06	2.47e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	3.82e-06	2.47e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—NQO1—Parkinson's disease	3.79e-06	2.45e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GPX1—Parkinson's disease	3.77e-06	2.44e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	3.76e-06	2.43e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—APOE—Parkinson's disease	3.76e-06	2.43e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—INS—Parkinson's disease	3.74e-06	2.42e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—INS—Parkinson's disease	3.74e-06	2.41e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—TH—Parkinson's disease	3.73e-06	2.41e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GPX1—Parkinson's disease	3.69e-06	2.39e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—APOE—Parkinson's disease	3.68e-06	2.38e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CYCS—Parkinson's disease	3.67e-06	2.37e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	3.66e-06	2.36e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NGF—Parkinson's disease	3.65e-06	2.36e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	3.61e-06	2.33e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—INS—Parkinson's disease	3.6e-06	2.33e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	3.59e-06	2.32e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CYCS—Parkinson's disease	3.58e-06	2.32e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NGF—Parkinson's disease	3.58e-06	2.31e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—NQO1—Parkinson's disease	3.57e-06	2.31e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	3.57e-06	2.31e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NGF—Parkinson's disease	3.56e-06	2.3e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	3.52e-06	2.28e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—TH—Parkinson's disease	3.52e-06	2.27e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	3.51e-06	2.27e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	3.51e-06	2.27e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	3.5e-06	2.26e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—INS—Parkinson's disease	3.48e-06	2.25e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—MTHFR—Parkinson's disease	3.48e-06	2.25e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MAOB—Parkinson's disease	3.47e-06	2.24e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	3.47e-06	2.24e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	3.41e-06	2.2e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—MTHFR—Parkinson's disease	3.41e-06	2.2e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	3.4e-06	2.2e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	3.39e-06	2.19e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CYCS—Parkinson's disease	3.38e-06	2.18e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	3.35e-06	2.17e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	3.34e-06	2.16e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	3.34e-06	2.16e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CTGF—Parkinson's disease	3.28e-06	2.12e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—COMT—Parkinson's disease	3.25e-06	2.1e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—APOE—Parkinson's disease	3.24e-06	2.09e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	3.24e-06	2.09e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—MAOA—Parkinson's disease	3.23e-06	2.09e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—APOE—Parkinson's disease	3.23e-06	2.09e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—INS—Parkinson's disease	3.22e-06	2.08e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	3.19e-06	2.06e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	3.18e-06	2.05e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—COMT—Parkinson's disease	3.17e-06	2.05e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—APOE—Parkinson's disease	3.17e-06	2.05e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—APOE—Parkinson's disease	3.17e-06	2.05e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GSTP1—Parkinson's disease	3.16e-06	2.04e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	3.16e-06	2.04e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CASP3—Parkinson's disease	3.16e-06	2.04e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CASP3—Parkinson's disease	3.15e-06	2.04e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—MAOA—Parkinson's disease	3.15e-06	2.04e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—APOE—Parkinson's disease	3.15e-06	2.03e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—INS—Parkinson's disease	3.14e-06	2.03e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—IL6—Parkinson's disease	3.14e-06	2.03e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—IL6—Parkinson's disease	3.13e-06	2.03e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—INS—Parkinson's disease	3.12e-06	2.02e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	3.12e-06	2.02e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—HMOX1—Parkinson's disease	3.12e-06	2.01e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	3.11e-06	2.01e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	3.06e-06	1.98e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	3.06e-06	1.98e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—NQO1—Parkinson's disease	3.02e-06	1.95e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—COMT—Parkinson's disease	2.99e-06	1.93e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—INS—Parkinson's disease	2.99e-06	1.93e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—TH—Parkinson's disease	2.98e-06	1.93e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	2.98e-06	1.93e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.98e-06	1.92e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	2.97e-06	1.92e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.97e-06	1.92e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	2.96e-06	1.91e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.94e-06	1.9e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.9e-06	1.88e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	2.9e-06	1.88e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	2.9e-06	1.87e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CYCS—Parkinson's disease	2.86e-06	1.85e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	2.85e-06	1.84e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GPX1—Parkinson's disease	2.85e-06	1.84e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	2.83e-06	1.83e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2.82e-06	1.82e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GPX1—Parkinson's disease	2.78e-06	1.8e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—INS—Parkinson's disease	2.77e-06	1.79e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—INS—Parkinson's disease	2.76e-06	1.78e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	2.74e-06	1.77e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	2.74e-06	1.77e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—INS—Parkinson's disease	2.71e-06	1.75e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—INS—Parkinson's disease	2.71e-06	1.75e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—INS—Parkinson's disease	2.71e-06	1.75e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—INS—Parkinson's disease	2.7e-06	1.74e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—INS—Parkinson's disease	2.69e-06	1.74e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	2.68e-06	1.73e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	2.66e-06	1.72e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—INS—Parkinson's disease	2.66e-06	1.72e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	2.66e-06	1.72e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	2.63e-06	1.7e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	2.62e-06	1.69e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GPX1—Parkinson's disease	2.62e-06	1.69e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.58e-06	1.67e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.57e-06	1.66e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—COMT—Parkinson's disease	2.53e-06	1.64e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.53e-06	1.64e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	2.52e-06	1.63e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MAOA—Parkinson's disease	2.52e-06	1.63e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	2.49e-06	1.61e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	2.47e-06	1.59e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—APOE—Parkinson's disease	2.45e-06	1.58e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	2.42e-06	1.56e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—APOE—Parkinson's disease	2.39e-06	1.54e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	2.39e-06	1.54e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.36e-06	1.53e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	2.34e-06	1.51e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.33e-06	1.51e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	2.33e-06	1.5e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	2.32e-06	1.5e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	2.32e-06	1.5e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	2.31e-06	1.49e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TH—Parkinson's disease	2.3e-06	1.49e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOE—Parkinson's disease	2.25e-06	1.46e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	2.23e-06	1.44e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GPX1—Parkinson's disease	2.22e-06	1.43e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	2.21e-06	1.43e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.21e-06	1.43e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	2.15e-06	1.39e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	2.14e-06	1.38e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—INS—Parkinson's disease	2.09e-06	1.35e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.05e-06	1.33e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	2.05e-06	1.32e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	2.05e-06	1.32e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—INS—Parkinson's disease	2.04e-06	1.32e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.04e-06	1.32e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	2.02e-06	1.31e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	2.02e-06	1.3e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	2.01e-06	1.3e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2.01e-06	1.3e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	2e-06	1.29e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	2e-06	1.29e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	2e-06	1.29e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	1.99e-06	1.29e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.98e-06	1.28e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	1.98e-06	1.28e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.97e-06	1.27e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	1.96e-06	1.27e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—COMT—Parkinson's disease	1.96e-06	1.26e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.95e-06	1.26e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.94e-06	1.26e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—INS—Parkinson's disease	1.92e-06	1.24e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.92e-06	1.24e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOE—Parkinson's disease	1.91e-06	1.23e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	1.89e-06	1.22e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	1.86e-06	1.2e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—Parkinson's disease	1.85e-06	1.2e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	1.85e-06	1.2e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—Parkinson's disease	1.85e-06	1.2e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.85e-06	1.19e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.84e-06	1.19e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	1.84e-06	1.19e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.82e-06	1.18e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	1.82e-06	1.17e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.79e-06	1.16e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—Parkinson's disease	1.75e-06	1.13e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.71e-06	1.11e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—Parkinson's disease	1.67e-06	1.08e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—INS—Parkinson's disease	1.63e-06	1.05e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.58e-06	1.02e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	1.57e-06	1.02e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOE—Parkinson's disease	1.47e-06	9.51e-06	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.37e-06	8.87e-06	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.36e-06	8.82e-06	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	1.31e-06	8.45e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—INS—Parkinson's disease	1.26e-06	8.13e-06	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.2e-06	7.79e-06	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.19e-06	7.66e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.18e-06	7.64e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	1.18e-06	7.62e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—Parkinson's disease	1.18e-06	7.6e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	1.16e-06	7.52e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.16e-06	7.5e-06	CbGpPWpGaD
